AMYLOID REPRIEVE

AMYLOID REPRIEVE:Courtesy of the National Institute on AgingAmyloid β is the cleavage product of Amyloid Precursor Protein (APP). Long suspected a culpable player in Alzheimer disease progression due to the plaques it forms, Aβ may have a physiological role depressing neuronal function.Recent work has revealed a potential physiological role for amyloid β, often considered a major culprit in Alzheimer disease (AD) pathology. This suggests that Aβ, an ordinarily upstanding prot

Written byJill Adams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Courtesy of the National Institute on Aging

Amyloid β is the cleavage product of Amyloid Precursor Protein (APP). Long suspected a culpable player in Alzheimer disease progression due to the plaques it forms, Aβ may have a physiological role depressing neuronal function.

Recent work has revealed a potential physiological role for amyloid β, often considered a major culprit in Alzheimer disease (AD) pathology. This suggests that Aβ, an ordinarily upstanding protein, turns bad as the result of a mob-type effect, when the physical buildup into plaques promotes neuronal damage and loss. "There's been a growing awareness over the last three or four years that it's not just a toxic peptide," says Hugh Pearson from the University of Leeds, UK.

Pearson used specific enzyme inhibitors to block β- and γ-secretase, which produce Aβ through the sequential cleavage of amyloid precursor protein (APP).1 Death occurred in neuronal cell lines but not in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies